{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:06:56Z","timestamp":1789024016548,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"MOST | National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1307600"],"award-info":[{"award-number":["2024YFA1307600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"DOI":"10.1038\/s44321-026-00508-3","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:00:15Z","timestamp":1786726815000},"page":"3423-3426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Population proteomics for equitable precision medicine"],"prefix":"10.1038","volume":"18","author":[{"given":"Xiaobo","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bomiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7686-0547","authenticated-orcid":false,"given":"Jin-tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"508_CR1","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41586-024-08280-5","volume":"636","author":"\u03c0-HuB Consortium","year":"2024","unstructured":"\u03c0-HuB Consortium (2024) \u03c0-HuB: the proteomic navigator of the human body. Nature 636:322\u2013331.","journal-title":"Nature"},{"key":"508_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold R, Mann M (2016) Mass-spectrometric exploration of proteome structure and function. Nature 537:347\u2013355","journal-title":"Nature"},{"key":"508_CR3","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/s41591-024-03164-7","volume":"30","author":"MA Argentieri","year":"2024","unstructured":"Argentieri MA, Xiao S, Bennett D, Winchester L, Nevado-Holgado AJ, Ghose U, Albukhari A, Yao P, Mazidi M, Lv J et al (2024) Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations. Nat Med 30:2450\u20132460","journal-title":"Nat Med"},{"key":"508_CR4","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1016\/j.cell.2026.04.032","volume":"189","author":"N Barapour","year":"2026","unstructured":"Barapour N, Cao JZ, Wu Y, Gupta S, Hoopmann MR, Qin R, Midha MK, Mireault M, Juanes-Velasco P, Hanson C et al (2026) A comparison of deep multiomics profiles across ethnicity, geography, and age. Cell 189:3004\u20133024.e35","journal-title":"Cell"},{"key":"508_CR5","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1038\/s41588-025-02319-7","volume":"57","author":"X Cai","year":"2025","unstructured":"Cai X, Geyer PE, Perez-Riverol Y, Omenn GS, Dong L, Winkler R, Ahadi S, Loessl P, Yu X, Chang C et al (2025) A standardized framework for circulating blood proteomics. Nat Genet 57:2371\u20132380","journal-title":"Nat Genet"},{"key":"508_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"Y-T Deng","year":"2025","unstructured":"Deng Y-T, You J, He Y, Zhang Y, Li H-Y, Wu X-R, Cheng J-Y, Guo Y, Long Z-W, Chen Y-L et al (2025) Atlas of the plasma proteome in health and disease in 53,026 adults. Cell 188:253\u2013271.e7","journal-title":"Cell"},{"key":"508_CR7","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.cell.2026.03.049","volume":"189","author":"M Koprulu","year":"2026","unstructured":"Koprulu M, Smith-Byrne K, Ferolito BR, Macdonald-Dunlop E, Luan J, Hedman \u00c5K, Ogamba CF, Kuliesius J, Repetto L, Ramisch A et al (2026) Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome. Cell 189:3339\u20133357","journal-title":"Cell"},{"key":"508_CR8","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s44161-024-00545-6","volume":"3","author":"L Lind","year":"2024","unstructured":"Lind L, Mazidi M, Clarke R, Bennett DA, Zheng R (2024) Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank. Nat Cardiovasc Res 3:1189\u20131198","journal-title":"Nat Cardiovasc Res"},{"key":"508_CR9","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.ard.2025.06.001","volume":"84","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhao M, Zhang L, Luo J, Cheng L, Zhan H, Li M, Zhang Z, Wang S, Feng X et al (2025) Autoantibody reactome analysis reveals diagnostic biomarkers and molecular classification for relapsing polychondritis. Ann Rheum Dis 84:2075\u20132087","journal-title":"Ann Rheum Dis"},{"key":"508_CR10","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1038\/s41467-023-37979-8","volume":"14","author":"Lung Cancer Cohort Consortium (LC3)","year":"2023","unstructured":"Lung Cancer Cohort Consortium (LC3) (2023) The blood proteome of imminent lung cancer diagnosis. Nat Commun 14:3042","journal-title":"Nat Commun"},{"key":"508_CR16","doi-asserted-by":"crossref","unstructured":"Mazidi M, Wright N, Yao P, Kartsonaki C, Millwood IY, Fry H, Said S, Pozarickij A, Pei P, Chen Y, et al (2024) Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenicscores in Chinese and European adults. Eur J Epidemiol 39:1229\u20131240","DOI":"10.1007\/s10654-024-01168-8"},{"key":"508_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo G, Williams SM, Tishkoff SA (2019) The missing diversity in human genetic studies. Cell 177:26\u201331","journal-title":"Cell"},{"key":"508_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41588-025-02421-w","volume":"58","author":"O Soremekun","year":"2026","unstructured":"Soremekun O, Park Y-C, Tutino M, Arruda AL, Kalungi A, Rayner NW, Nyirenda M, Fatumo S, Zeggini E (2026) Linking the plasma proteome to genetics in individuals from continental Africa provides insights into type 2 diabetes pathogenesis. Nat Genet 58:39\u201346","journal-title":"Nat Genet"},{"key":"508_CR17","doi-asserted-by":"crossref","unstructured":"Yao P, Iona A, Pozarickij A, Said S, Wright N, Lin K, Millwood I, Fry H, Kartsonaki C, Mazidi M, et al (2024) Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2diabetes. Diabetes Care 47:1012\u20131019","DOI":"10.2337\/dc23-2145"},{"key":"508_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202511535","volume":"12","author":"J Yi","year":"2025","unstructured":"Yi J, Xu M, Han L, Dong Z, Liu R, Zhang X, Hu D, Lu C, Yu X (2025) A multicenter validation of a fully automated chemiluminescence immunoassay for plasma Elafin in psoriasis diagnosis and severity assessment. Adv Sci 12:e11535","journal-title":"Adv Sci"},{"key":"508_CR14","doi-asserted-by":"crossref","unstructured":"Zahed H, Feng X, Alcala K, Smith-Byrne K, Moez E, Guida F, Albanes D, Weinstein SJ, Arslan AA, Cai Q et al (2026) Biomarker-based eligibility for lung cancer screening: validation of the protein-based INTEGRAL-Risk model. JAMA. 336:323\u2013333","DOI":"10.1001\/jama.2026.8044"},{"key":"508_CR15","doi-asserted-by":"crossref","unstructured":"Zhang J, Dutta D, K\u00f6ttgen A, Tin A, Schlosser P, Grams ME, Harvey B, CKDGen Consortium, Yu B, Boerwinkle E et al (2022) Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat Genet 54:593\u2013602","DOI":"10.1038\/s41588-022-01051-w"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00508-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:31:48Z","timestamp":1789021908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00508-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,10]]}},"alternative-id":["508"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00508-3","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"XY is the founder of ProteomicsEra. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}